Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Astria Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +13 vs. Q2 2022
- Shares held
- 9.83M
- +4.10M (+71.5%) vs. Q2 2022
- Total value
- $88.8M
- +$71.7M (+416.7%) vs. Q2 2022
- New holders
- 15
- 11 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SOA Wealth Advisors, LLC. | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 60 | $1.00K | 0.00% | −4−6.3% | Reduced |
| Key Financial Inc | 66 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 119 | $1.08K | 0.00% | +119 | New |
| Benjamin F. Edwards & Company, Inc. | 333 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 299 | $3.00K | 0.00% | +299 | New |
| Tower Research Capital LLC (TRC) | 793 | $7.00K | 0.00% | −1,280−61.7% | Reduced |
| UBS Group AG | 3,262 | $29.0K | 0.00% | +3,237+12,948.0% | Added |
| Bank of America Corp | 8,092 | $73.0K | 0.00% | +7,527+1,332.2% | Added |
| Group One Trading, L.P. | 8,500 | $77.0K | 0.00% | −2,931−25.6% | Reduced |
| Morgan Stanley | 10,705 | $97.0K | 0.00% | +8,204+328.0% | Added |
| Acadian Asset Management LLC | 11,461 | $103.0K | 0.00% | +11,461 | New |
| Jump Financial, LLC | 12,000 | $108.0K | 0.00% | +12,000 | New |
| Cubist Systematic Strategies, LLC | 14,666 | $133.0K | 0.00% | +14,666 | New |
| Dimensional Fund Advisors LP | 17,521 | $158.0K | 0.00% | +17,521 | New |
| Oppenheimer & Co Inc | 17,816 | $161.0K | 0.00% | −5,800−24.6% | Reduced |
| Northern Trust Corp | 19,593 | $177.0K | 0.00% | −316−1.6% | Reduced |
| Millennium Management LLC | 20,710 | $187.0K | 0.00% | +3,793+22.4% | Added |
| Jane Street Group, LLC | 21,498 | $194.0K | 0.00% | +21,498 | New |
| Botty Investors LLC | 24,331 | $220.0K | 0.09% | −1,416−5.5% | Reduced |
| Samsara BioCapital, LLC | 25,000 | $226.0K | 0.05% | 00.0% | Unchanged |
| State Street Corp | 29,082 | $263.0K | 0.00% | +29,082 | New |
| Artal Group S.A. | 33,333 | $301.0K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 35,000 | $316.0K | 0.01% | −79,279−69.4% | Reduced |
| Renaissance Technologies LLC | 57,861 | $523.0K | 0.00% | +44,161+322.3% | Added |
| BlackRock Inc. | 78,325 | $708.0K | 0.00% | +16,868+27.4% | Added |
| Boothbay Fund Management, LLC | 101,619 | $919.0K | 0.03% | +25,846+34.1% | Added |
| Geode Capital Management, LLC | 111,905 | $1.01M | 0.00% | +27,709+32.9% | Added |
| Citadel Advisors LLC | 122,476 | $1.11M | 0.00% | −97,486−44.3% | Reduced |
| Opaleye Management Inc. | 133,500 | $1.21M | 0.50% | +133,500 | New |
| Alyeska Investment Group, L.P. | 274,719 | $2.48M | 0.03% | 00.0% | Unchanged |
| FMR LLC | 377,445 | $3.41M | 0.00% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 400,043 | $3.62M | 1.67% | +400,043 | New |
| Altium Capital Management LP | 445,000 | $4.02M | 1.51% | +445,000 | New |
| Ghost Tree Capital, LLC | 500,000 | $4.52M | 1.85% | +500,000 | New |
| Vanguard Group Inc | 531,153 | $4.80M | 0.00% | +27,743+5.5% | Added |
| Tri Locum Partners LP | 631,579 | $5.71M | 1.63% | +631,579 | New |
| Driehaus Capital Management LLC | 656,361 | $5.93M | 0.09% | +656,361 | New |
| Ikarian Capital, LLC | 699,440 | $6.32M | 3.16% | +107,317+18.1% | Added |
| Fairmount Funds Management LLC | 911,736 | $8.24M | 1.52% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,000,000 | $9.04M | 1.00% | +1,000,000 | New |
| Cormorant Asset Management, LP | 1,200,000 | $10.8M | 0.76% | +900,000+300.0% | Added |
| Perceptive Advisors LLC | 1,281,197 | $11.6M | 0.34% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −760,857−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |